摘要
背景:真菌是具有治疗意义的化合物且非常有价值,特别是新型抗癌化合物。虽然很少通过与天然来源隔离而获得,但总的有机合成仍然是向其补给的最有效的替代方法之一。此外,天然产物全合成不仅是发现新的复杂生物活性化合物的有价值的工具,而且也是开发对映选择性有机合成中的创新方法学的有用工具。 方法:采用化学文献数据库(SciFinder,Reaxys)进行深入的文献检索,以便对广泛的研究领域有一个全面的了解。然后筛选文献,根据生物活性和创新性合成程序的主题术语对获得的结果进行改进。 结果:最近对有关真菌代谢物的文献进行了审查,并且这些出版物已被用作研究基础文献,从中我们考虑在抗癌性质和药物开发方面最有前景的化合物的合成可行性。在本文中,化合物根据其化学结构进行分类。 结论:本综述总结了真菌代谢产物的抗癌潜力,强调了总合成的作用,概括了促进真菌代谢产物进入药物的创新合成程序的可行性,这可能成为未来真正的前景。据我们所知,这次审查是第一个努力来处理这些活性真菌代谢产物的全面合成,并表明在最近的技术和创新进步的帮助下,全化学合成是产生真菌衍生物的富有成效的手段。
关键词: 真菌抗癌代谢物,合成,药物发现,含氮化合物,真菌,生物活性。
Current Medicinal Chemistry
Title:Fungal Anticancer Metabolites: Synthesis Towards Drug Discovery
Volume: 25 Issue: 2
关键词: 真菌抗癌代谢物,合成,药物发现,含氮化合物,真菌,生物活性。
摘要: Background: Fungi are a well-known and valuable source of compounds of therapeutic relevance, in particular of novel anticancer compounds. Although seldom obtainable through isolation from the natural source, the total organic synthesis still remains one of the most efficient alternatives to resupply them. Furthermore, natural product total synthesis is a valuable tool not only for discovery of new complex biologically active compounds but also for the development of innovative methodologies in enantioselective organic synthesis.
Methods: We undertook an in-depth literature searching by using chemical bibliographic databases (SciFinder, Reaxys) in order to have a comprehensive insight into the wide research field. The literature has been then screened, refining the obtained results by subject terms focused on both biological activity and innovative synthetic procedures.
Results: The literature on fungal metabolites has been recently reviewed and these publications have been used as a base from which we consider the synthetic feasibility of the most promising compounds, in terms of anticancer properties and drug development. In this paper, compounds are classified according to their chemical structure.
Conclusion: This review summarizes the anticancer potential of fungal metabolites, highlighting the role of total synthesis outlining the feasibility of innovative synthetic procedures that facilitate the development of fungal metabolites into drugs that may become a real future perspective. To our knowledge, this review is the first effort to deal with the total synthesis of these active fungi metabolites and demonstrates that total chemical synthesis is a fruitful means of yielding fungal derivatives as aided by recent technological and innovative advancements.
Export Options
About this article
Cite this article as:
Fungal Anticancer Metabolites: Synthesis Towards Drug Discovery, Current Medicinal Chemistry 2018; 25 (2) . https://dx.doi.org/10.2174/0929867324666170511112815
DOI https://dx.doi.org/10.2174/0929867324666170511112815 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Algae Biotechnology – Green Cell-Factories on the Rise
Current Biotechnology Current Scenario of Acridine Hybrids with Anticancer Potential
Current Topics in Medicinal Chemistry Nitric Oxide: Target for Therapeutic Strategies in Alzheimers Disease
Current Pharmaceutical Design Endothelial Remodelling and Intracellular Calcium Machinery
Current Molecular Medicine Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
Current Drug Targets The Ubiquitin-Proteasome System and Proteasome Inhibitors in Central Nervous System Diseases
Cardiovascular & Hematological Disorders-Drug Targets Promote Recurrent Aphthous Ulcer Healing with Low Dose Prednisolone Bilayer Mucoadhesive Buccal Film
Current Drug Delivery Design, Synthesis, and Bioactivity of Pyrazole Acid Derivatives as Endothelin Receptor Antagonists
Medicinal Chemistry Molecular Imaging of Matrix Metalloproteinases In Vivo Using Small Molecule Inhibitors for SPECT and PET
Current Medicinal Chemistry How Insulin Receptor Substrate Proteins Regulate the Metabolic Capacity of the Liver - Implications for Health and Disease
Current Medicinal Chemistry Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Current Pharmaceutical Design CCR2 Antagonists
Current Topics in Medicinal Chemistry ADP-Ribosyl Cyclase as a Therapeutic Target for Central Nervous System Diseases
Central Nervous System Agents in Medicinal Chemistry Clinical Development of mTOR Inhibitors: A Focus on Lymphoma
Reviews on Recent Clinical Trials MMP Inhibitors in Cardiac Diseases: An Update
Recent Patents on Cardiovascular Drug Discovery Fishing Anti-Inflammatories from Known Drugs: In Silico Repurposing, Design, Synthesis and Biological Evaluation of Bisacodyl Analogues
Current Topics in Medicinal Chemistry Resveratrol in Medicinal Chemistry: A Critical Review of its Pharmacokinetics, Drug-Delivery, and Membrane Interactions
Current Medicinal Chemistry Design, Synthesis and Docking Study of Some Novel Isatin- Quinoline Hybrids as Potential Antitubercular Agents
Anti-Infective Agents Protective Effects of Chronic Green Tea Consumption on Age-related Neurodegeneration
Current Pharmaceutical Design Renal Cell Cancer and Positron Emission Tomography- an Evolving Diagnostic and Therapeutic Relationship
Current Medical Imaging